Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07600047 · ClinicalTrials.gov registry record · NA

A Well-Being Intervention for People With IBS

A NA study, sponsored by University of Wisconsin, Madison.

Not yet
Registry status
NA
Development phase
150
Enrollment target

NCT07600047: Clinical Trial NA study, sponsored by University of Wisconsin, Madison.

NCT07600047 is a NA study that has not yet begun recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07600047, a NA study, has not yet begun recruiting, sponsored by University of Wisconsin, Madison.

NOT YET RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

The purpose of this randomized behavioral clinical trial is to examine whether a well-being intervention can improve both psychological well-being and physical outcomes in adults with Irritable Bowel Syndrome (IBS). The study aims to assess whether this intervention decreases anger, anxiety, and depression; increases self-esteem, empathy, and hope; and improves quality of life indicators such as IBS symptom severity, sleep quality, fatigue, and diet. Participants can expect to be on study for up to 9 months.

Primary Outcome

The Patient-Reported Outcomes Measurement Information System (PROMIS) Anger Scale is scored from 5-25 where higher scores indicates more anger.

Interventions

  • BEHAVIORAL Well-Being Intervention

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2026-08
Est. Completion 2027-08
Phase NA
University of Wisconsin, Madison

1,039 total trials

What is known before NCT07600047 opens enrollment

NCT07600047 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 1 intervention - of which Well-Being Intervention is the first listed.

NCT07600047 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07600047 about?

NCT07600047 is a clinical study titled "A Well-Being Intervention for People With IBS". The purpose of this randomized behavioral clinical trial is to examine whether a well-being intervention can improve both psychological well-being and physical outcomes in adults with Irritable Bowel Syndrome (IBS). The study aims to assess whether this intervention decreases anger, anxiety, and dep...

What is the current status of trial NCT07600047?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2026-08. Estimated completion is 2027-08.

What interventions are being tested in trial NCT07600047?

The interventions under investigation include: Well-Being Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT07600047?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07600047's enrollment target sits among peer trials

150 661st of 2000 higher than 1,299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07600047, the US trial registry maintained by the National Library of Medicine. NCT07600047 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.